Sign In

Dana Bliuc

Senior Research Officer at Garvan Institute of Medical Research

Dr. Dana Bliuc is a Senior Research Officer at the Garvan Institute of Medical Research and a Senior Lecturer at the School of Population Health, UNSW Sydney.12 She is a clinical epidemiologist with over 15 years of expertise in fracture epidemiology.2

Dr. Bliuc's educational background includes:

  • PhD in Epidemiology from UNSW
  • Master's in Medicine from UNSW
  • MD from the University of Medicine and Pharmacy Gr. T. Popa, Romania2

Her research focuses on:

  1. Determining adverse outcomes associated with osteoporotic fractures
  2. Effectiveness and safety of osteoporosis medicines in real-world settings
  3. Impact of multimorbidity on osteoporosis medication prescription and outcomes2

Dr. Bliuc has made significant contributions to fracture epidemiology, including:

  • Demonstrating high risk of long-term adverse events associated with osteoporotic fractures
  • Providing evidence on the role of nitrogen-bisphosphonates in mortality risk reduction
  • Leading the NSW Linked Cohort study, focusing on the impact of multimorbidity on fracture outcomes and osteoporosis treatment2

She has received several awards, including:

  • 2021 Australian and NZ Bone and Mineral Society (ANZBMS) Outstanding Abstract Award
  • 2015 ANZBMS Sol Posen Best Publication Award
  • 2015 International Society for Bone and Mineral Research Young Investigator International Travel Award2

Dr. Bliuc is actively involved in research supervision, media engagement, and teaching, including co-convening the Foundations of Epidemiology Course (PHCM9794) at UNSW.23

Highlights

Jan 26 · linkedin

A simple but powerful message. Very proud of our work published in Jama Network Open

Related Questions

What are Dana Bliuc's most significant research contributions?
How has Dana Bliuc's work impacted osteoporosis treatment guidelines?
What are the main findings from Dana Bliuc's studies on fracture mortality?
Can you provide more details about Dana Bliuc's role in the International Consortium?
What are the key outcomes from Dana Bliuc's pharmaco-epidemiological studies?
Dana Bliuc
Dana Bliuc, photo 1
Dana Bliuc, photo 2
Add to my network

Location

Greater Sydney Area